TWI515013B - Skin detergent composition - Google Patents
Skin detergent composition Download PDFInfo
- Publication number
- TWI515013B TWI515013B TW100133957A TW100133957A TWI515013B TW I515013 B TWI515013 B TW I515013B TW 100133957 A TW100133957 A TW 100133957A TW 100133957 A TW100133957 A TW 100133957A TW I515013 B TWI515013 B TW I515013B
- Authority
- TW
- Taiwan
- Prior art keywords
- detergent composition
- mass
- polyoxyethylene
- skin detergent
- ethylene oxide
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 64
- 239000003599 detergent Substances 0.000 title claims description 47
- -1 fatty acid salt Chemical class 0.000 claims description 72
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 64
- 239000004973 liquid crystal related substance Substances 0.000 claims description 56
- 239000004359 castor oil Substances 0.000 claims description 37
- 235000019438 castor oil Nutrition 0.000 claims description 37
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 37
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 34
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 26
- 239000000194 fatty acid Substances 0.000 claims description 26
- 229930195729 fatty acid Natural products 0.000 claims description 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 25
- 239000002736 nonionic surfactant Substances 0.000 claims description 21
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 17
- 235000011187 glycerol Nutrition 0.000 claims description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 239000002280 amphoteric surfactant Substances 0.000 claims description 10
- 229920006395 saturated elastomer Polymers 0.000 claims description 10
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 229940068918 polyethylene glycol 400 Drugs 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 229940113115 polyethylene glycol 200 Drugs 0.000 claims description 3
- 229940068886 polyethylene glycol 300 Drugs 0.000 claims description 3
- 229940057847 polyethylene glycol 600 Drugs 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 229960002920 sorbitol Drugs 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- OJLUNOVIEXMXNJ-UHFFFAOYSA-N C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(C(O)CO)OCC(O)CO Chemical compound C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(C(O)CO)OCC(O)CO OJLUNOVIEXMXNJ-UHFFFAOYSA-N 0.000 claims 1
- QGAZOZMCHNIBKD-UHFFFAOYSA-N C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)(=O)O.CCCC Chemical compound C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)(=O)O.CCCC QGAZOZMCHNIBKD-UHFFFAOYSA-N 0.000 claims 1
- SSQFQZRTVJEMDA-UHFFFAOYSA-N C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.C(C(O)CO)OCC(O)CO Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.C(C(O)CO)OCC(O)CO SSQFQZRTVJEMDA-UHFFFAOYSA-N 0.000 claims 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 150000002923 oximes Chemical class 0.000 claims 1
- 239000008159 sesame oil Substances 0.000 claims 1
- 235000011803 sesame oil Nutrition 0.000 claims 1
- 150000005846 sugar alcohols Polymers 0.000 claims 1
- 239000000839 emulsion Substances 0.000 description 22
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 22
- 150000002430 hydrocarbons Chemical group 0.000 description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 238000003860 storage Methods 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 229960003237 betaine Drugs 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 7
- 229920005862 polyol Polymers 0.000 description 7
- 150000003077 polyols Chemical class 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 239000000693 micelle Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 125000005456 glyceride group Chemical group 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- DJXPNUIRGNRCPQ-UHFFFAOYSA-N 2-[2,3-bis[2-(16-methylheptadecanoyloxy)ethoxy]propoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCC(COCCOC(=O)CCCCCCCCCCCCCCC(C)C)OCCOC(=O)CCCCCCCCCCCCCCC(C)C DJXPNUIRGNRCPQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 3
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N (9e,12z)-octadeca-9,12-dienoic acid Chemical compound CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 238000000333 X-ray scattering Methods 0.000 description 2
- LGGCWJVUVOLOGK-UHFFFAOYSA-N acetic acid dodecyl 2-(dimethylamino)acetate Chemical compound CC(O)=O.CCCCCCCCCCCCOC(=O)CN(C)C LGGCWJVUVOLOGK-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- IHSPMDXQWYKHOA-UHFFFAOYSA-N dodecyl 2-(dimethylamino)acetate Chemical compound CCCCCCCCCCCCOC(=O)CN(C)C IHSPMDXQWYKHOA-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 150000002169 ethanolamines Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- WBHHMMIMDMUBKC-QJWNTBNXSA-N ricinoleic acid Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O WBHHMMIMDMUBKC-QJWNTBNXSA-N 0.000 description 2
- 229960003656 ricinoleic acid Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000235 small-angle X-ray scattering Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000271 synthetic detergent Substances 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- HRLPTSDRCFNHPE-UHFFFAOYSA-N 2,2,3,3-tetramethylnonanoic acid Chemical compound CCCCCCC(C)(C)C(C)(C)C(O)=O HRLPTSDRCFNHPE-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- XIMFTYYMYOBGOG-UHFFFAOYSA-N 2-hydroxy-2-(2-oxo-2-propoxyethyl)butanedioic acid Chemical compound CCCOC(=O)CC(O)(C(O)=O)CC(O)=O XIMFTYYMYOBGOG-UHFFFAOYSA-N 0.000 description 1
- XSUPXKHTYKPZKM-UHFFFAOYSA-N 2-hydroxy-4-oxo-2-(2-oxo-2-propoxyethyl)-4-propoxybutanoic acid Chemical compound CCCOC(=O)CC(O)(C(O)=O)CC(=O)OCCC XSUPXKHTYKPZKM-UHFFFAOYSA-N 0.000 description 1
- WXBXVVIUZANZAU-UHFFFAOYSA-N 2E-decenoic acid Natural products CCCCCCCC=CC(O)=O WXBXVVIUZANZAU-UHFFFAOYSA-N 0.000 description 1
- OILUAKBAMVLXGF-UHFFFAOYSA-N 3,5,5-trimethyl-hexanoic acid Chemical compound OC(=O)CC(C)CC(C)(C)C OILUAKBAMVLXGF-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- DAJLAGXWHUJVLS-UHFFFAOYSA-N C(CC(O)(C(=O)O)CC(=O)O)(=O)OCCC.N1=C(N)N=C(N)N=C1N Chemical compound C(CC(O)(C(=O)O)CC(=O)O)(=O)OCCC.N1=C(N)N=C(N)N=C1N DAJLAGXWHUJVLS-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- NTOPKICPEQUPPH-UHFFFAOYSA-N IPMP Natural products COC1=NC=CN=C1C(C)C NTOPKICPEQUPPH-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BAZMYXGARXYAEQ-UHFFFAOYSA-N alpha-ethyl valeric acid Chemical compound CCCC(CC)C(O)=O BAZMYXGARXYAEQ-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- JMOLZNNXZPAGBH-UHFFFAOYSA-N hexyldecanoic acid Chemical compound CCCCCCCCC(C(O)=O)CCCCCC JMOLZNNXZPAGBH-UHFFFAOYSA-N 0.000 description 1
- 229950004531 hexyldecanoic acid Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000013042 solid detergent Substances 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- WXBXVVIUZANZAU-CMDGGOBGSA-N trans-2-decenoic acid Chemical compound CCCCCCC\C=C\C(O)=O WXBXVVIUZANZAU-CMDGGOBGSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Description
本發明係關於高溫、低溫保存時之安定性佳,即使手濕的狀態亦有良好的使用性之液晶狀態之皮膚洗淨劑組成物者。The present invention relates to a skin cleansing agent composition which is excellent in stability at high temperature and low temperature storage, and which has a good usability in a liquid state even if the hand is wet.
半固體狀之洗淨劑組成物係可保持磨砂等粒子分散於該製劑中的狀態,可提升外觀美麗,或使用感。其中,具有透明自半透明之外觀的膠狀洗淨劑係可提供給消費者高品質感。The semi-solid detergent composition can maintain a state in which particles such as frosting are dispersed in the preparation, and can improve the appearance and the feeling of use. Among them, a gel-like detergent having a transparent and translucent appearance can provide a high quality feeling to the consumer.
含高級脂肪酸鹽之洗淨劑組成物係起泡性能、沖洗性能佳,但成半固體狀時,有性能、安定性不良之課題。例如揭示使用高級脂肪酸鹽與烷基丙烯酸聚合物(Alkyl acrylate copolymer)之透明膠狀皮膚洗淨劑(專利文獻1:特開2007-126396號公報)。然而,雖然外觀為透明膠狀,但因為以高分子化合物增黏而成膠狀,所以起泡慢,因為以手取用製劑時牽絲,所以使用性不佳。The detergent composition containing a higher fatty acid salt is excellent in foaming performance and rinsing performance, but when it is semi-solid, it has a problem of poor performance and stability. For example, a transparent gel-like skin cleansing agent using a higher fatty acid salt and an Alkyl acrylate copolymer is disclosed (Patent Document 1: JP-A-2007-126396). However, although the appearance is a transparent gel, since the polymer compound is viscous and gelatinized, the foaming is slow, and since the yarn is taken by hand when the preparation is taken, the usability is not good.
另外,揭示使用特定的高級脂肪酸鹽、兩性界面活性劑、甘油及脂肪酸烷醇醯胺型非離子性界面活性劑之透明膠狀洗淨劑(專利文獻2:特開2007-51168號公報)。因為此並非以高分子化合物增黏,而是以界面活性劑之液晶相而膠化,所以使用時不易發生牽絲,但因黏性高,難以自容器取出,進一步加水時亦難以塗開製劑,有自手掉落之課題。Further, a transparent colloidal detergent using a specific high-grade fatty acid salt, an amphoteric surfactant, glycerin, and a fatty acid alkanosamine-type nonionic surfactant is disclosed (Patent Document 2: JP-A-2007-51168). Since this is not a viscosity of a polymer compound, but is gelled by a liquid crystal phase of a surfactant, it is less likely to be drawn during use, but it is difficult to remove from the container due to high viscosity, and it is difficult to apply the formulation when further adding water. There is a problem of falling by hand.
先前技術文獻Prior technical literature
專利文獻Patent literature
專利文獻1:特開2007-126396號公報Patent Document 1: JP-A-2007-126396
專利文獻2:特開2007-51168號公報Patent Document 2: JP-A-2007-51168
本發明係有鑑於前述情況,以提供高溫、低溫保存時之安定性佳,即使手濕的狀態亦有良好的使用性之液晶狀態之皮膚洗淨劑組成物為目的。In view of the above, the present invention has an object of providing a skin cleansing agent composition having a good usability in a liquid crystal state even when the hand is wet and is excellent in stability at high temperature and low temperature storage.
本發明者等為達成前述目的,努力研究的結果係發現分別以特定量添加(A)高級脂肪酸鹽、(B)甜菜鹼型兩性界面活性劑、(C)特定之非離子性界面活性劑、及(D)多元醇,製成於25℃時為液晶狀態,透明之皮膚洗淨劑組成物,於高溫、低溫保存時之安定性佳,即使手濕的狀態亦可有良好的使用性(容易溶解、起泡),達成完成本發明。In order to achieve the above object, the inventors of the present invention have found that (A) a higher fatty acid salt, (B) a betaine type amphoteric surfactant, (C) a specific nonionic surfactant, and a specific amount are added, respectively. And (D) a polyol which is made into a liquid crystal state at 25 ° C, and a transparent skin detergent composition which has good stability at high temperature and low temperature storage, and has good usability even in a wet state ( It is easy to dissolve and foam, and the present invention has been completed.
因此,本發明係提供下述皮膚洗淨劑組成物。Accordingly, the present invention provides the following skin cleanser compositions.
[1]含有下述(A)、(B)、(C)及(D)成份,且於25℃時為液晶狀態為特徵之皮膚洗淨劑組成物。[1] A skin cleansing composition comprising the following components (A), (B), (C) and (D) and having a liquid crystal state at 25 °C.
(A)碳數8~26之高級脂肪酸鹽,15~45質量%,(A) a higher fatty acid salt having a carbon number of 8 to 26, 15 to 45% by mass,
(B)甜菜鹼型兩性界面活性劑,7~25質量%,(B) betaine type amphoteric surfactant, 7 to 25% by mass,
(C)下述非離子性界面活性劑,1~5質量%;(C) the following nonionic surfactant, 1 to 5% by mass;
為聚氧乙烯(環氧乙烷之平均加成莫耳數10~80)甘油酯、甘油、或聚氧乙烯(環氧乙烷之平均加成莫耳數10~80)三羥甲基丙烷的3個羥基經酯化或醚化的化合物,酯化或醚化的部份係碳數7~25的飽和或不飽和,直鏈或支鏈的一價烴基,亦可部份氫原子為羥基所取代,亦可於此羥基加成平均加成莫耳數為10~80之聚氧乙烯,但是,非離子性界面活性劑所加成之聚氧乙烯總數係平均加成莫耳數為10~80。It is a polyoxyethylene (average addition molar number of ethylene oxide of 10 to 80) glycerol ester, glycerin, or polyoxyethylene (average addition molar number of ethylene oxide 10 to 80) trimethylolpropane a compound in which three hydroxyl groups are esterified or etherified, and the esterified or etherified portion is a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms, or a part of a hydrogen atom. The hydroxyl group may be substituted, and the hydroxyl group may be added to form a polyoxyethylene having a molar number of 10 to 80. However, the total number of polyoxyethylene added by the nonionic surfactant is an average addition molar number. 10 to 80.
(D)多元醇,15~35質量%。(D) Polyol, 15 to 35 mass%.
[2] (C)成份中酯化或醚化部份之碳數7~25的一價烴基係部份氫原子為羥基所取代為特徵之[1]記載之皮膚洗淨劑組成物。[2] (C) A skin detergent composition according to [1], characterized in that the hydrogen atom of the esterified or etherified portion of the component is 7 to 25 and the hydrogen atom of the monovalent hydrocarbon group is a hydroxyl group.
[3] (C)成份係聚氧乙烯氫化萞麻油或聚氧乙烯萞麻油之[1]或[2]記載之皮膚洗淨劑組成物。[3] The component (C) is a skin detergent composition according to [1] or [2] of polyoxyethylene hydrogenated castor oil or polyoxyethylene castor oil.
[4] 液晶係六角(hexagonal)液晶之[1]、[2]或[3]記載之皮膚洗淨劑組成物。[4] A liquid detergent composition according to [1], [2] or [3] of a liquid crystal hexagonal liquid crystal.
依據本發明,可提供於高溫、低溫保存時之安定性佳,即使手濕的狀態亦有良好的使用性之液晶狀態之皮膚洗淨劑組成物。According to the present invention, it is possible to provide a skin detergent composition which is excellent in stability at high temperature and low temperature storage, and which has a good usability liquid state even in a wet state.
用以實施發明之最佳型態The best form for implementing the invention
以下係詳細說明關於本發明。The following is a detailed description of the invention.
本發明之皮膚洗淨劑組成物係以含有下述(A)、(B)、(C)及(D)成份,且於25℃時為液晶狀態為特徵之皮膚洗淨劑組成物。The skin detergent composition of the present invention is a skin detergent composition characterized by containing the following components (A), (B), (C) and (D) and having a liquid crystal state at 25 °C.
(A)碳數8~26之高級脂肪酸鹽,15~45質量%(A) a higher fatty acid salt having a carbon number of 8 to 26, 15 to 45% by mass
(B)甜菜鹼型兩性界面活性劑,7~25質量%(B) Betaine type amphoteric surfactant, 7 to 25% by mass
(C)下述非離子性界面活性劑,1~5質量%(C) the following nonionic surfactant, 1 to 5% by mass
為聚氧乙烯(環氧乙烷之平均加成莫耳數10~80)甘油酯、甘油、或聚氧乙烯(環氧乙烷之平均加成莫耳數10~80)三羥甲基丙烷的3個羥基經酯化或醚化的化合物,酯化或醚化的部份係碳數7~25的飽和或不飽和,直鏈或支鏈的一價烴基,亦可部份氫原子為羥基所取代,亦可於此羥基加成平均加成莫耳數為10~80之聚氧乙烯,但是,非離子性界面活性劑所加成之聚氧乙烯總數係平均加成莫耳數為10~80。It is a polyoxyethylene (average addition molar number of ethylene oxide of 10 to 80) glycerol ester, glycerin, or polyoxyethylene (average addition molar number of ethylene oxide 10 to 80) trimethylolpropane a compound in which three hydroxyl groups are esterified or etherified, and the esterified or etherified portion is a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms, or a part of a hydrogen atom. The hydroxyl group may be substituted, and the hydroxyl group may be added to form a polyoxyethylene having a molar number of 10 to 80. However, the total number of polyoxyethylene added by the nonionic surfactant is an average addition molar number. 10 to 80.
(D)多元醇,15~35質量%(D) Polyol, 15 to 35 mass%
(A)高級脂肪酸鹽(A) Higher fatty acid salts
本發明之(A)高級脂肪酸鹽係碳數8~26之高級脂肪酸鹽,一價烴基部份可為直鏈或支鏈,飽和或不飽和中任一種皆可,可單獨1種或適當組合2種以上使用。其中以下述一般式(1)所示之高級脂肪酸鹽為宜。The (A) higher fatty acid salt of the present invention is a higher fatty acid salt having 8 to 26 carbon atoms, and the monovalent hydrocarbon group may be linear or branched, and either one of saturated or unsaturated may be used alone or in combination. Two or more types are used. Among them, a higher fatty acid salt represented by the following general formula (1) is preferred.
R1COOM (1)R 1 COOM (1)
(式中,R1係表示7~25的直鏈或支鏈,飽和或不飽和的一價烴基,此一價烴基之氫原子的部份或全部可為羥基所取代。M係表示鉀、鈉、單乙醇胺、二乙醇胺、三乙醇胺、2-胺基-2-甲基-1-丙醇或二異丙醇胺。)(wherein R 1 represents a straight or branched chain of 7 to 25, a saturated or unsaturated monovalent hydrocarbon group, and part or all of the hydrogen atom of the monovalent hydrocarbon group may be substituted with a hydroxyl group. M means potassium, Sodium, monoethanolamine, diethanolamine, triethanolamine, 2-amino-2-methyl-1-propanol or diisopropanolamine.)
作為(A)成份,可舉例如己酸、庚酸、辛酸、壬酸、癸酸、十一烷酸、月桂酸、癸烯酸、十一碳烯酸、月桂烯酸、2-乙基丁酸、異戊酸、2-乙基戊酸、2-乙基己酸、異壬酸、3,5,5-三甲基己酸、十三烷酸、四甲基壬酸、肉豆蔻酸、十五烷酸、棕櫚酸、硬脂酸、花生酸、二十二烷酸、二十四烷酸、二十六烷酸、肉豆蔻烯酸、棕櫚烯酸、油酸、反油酸、二十二碳烯酸、芥酸、鯊油酸、亞油酸、反-9,順-12-十八碳二烯酸、亞麻酸、花生浸烯酸、2-己基癸酸、異硬脂酸、12-羥基硬脂酸、月桂酸、肉豆蔻酸、棕櫚酸、癸酸等之混合物或椰子油脂肪酸等之鹽。The (A) component may, for example, be caproic acid, heptanoic acid, caprylic acid, capric acid, capric acid, undecanoic acid, lauric acid, decenoic acid, undecylenic acid, lauric acid, 2-ethylbutyl Acid, isovaleric acid, 2-ethylpentanoic acid, 2-ethylhexanoic acid, isophthalic acid, 3,5,5-trimethylhexanoic acid, tridecanoic acid, tetramethylnonanoic acid, myristic acid , pentadecanoic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, tetracosanoic acid, hexadecanoic acid, myristoleic acid, palmitoleic acid, oleic acid, oleic acid, Dodecanoic acid, erucic acid, squalic acid, linoleic acid, trans-9, cis-12-octadecadienoic acid, linolenic acid, arachidonic acid, 2-hexyl decanoic acid, isostearyl A mixture of acid, 12-hydroxystearic acid, lauric acid, myristic acid, palmitic acid, citric acid or the like or a salt of coconut oil fatty acid or the like.
其中,以碳數10、12、14、16之癸酸鹽、月桂酸鹽、肉豆蔻酸鹽、棕櫚酸鹽為宜。碳數未滿10時,於高溫的安定性差,若超過16時,於低溫的安定性差。碳數12以下之高級脂肪酸鹽及碳數14以上的高級脂肪酸鹽的質量比係以80/20~40/60為宜,以75/25~50/50尤佳,以70/30~60/40更好。碳數12以下的高級脂肪酸鹽的比若超過80/20時,高溫安定性差,若未滿40/60時,低溫安定性與對水的溶解性可能會變差。Among them, a citrate having a carbon number of 10, 12, 14, or 16 is preferably a laurate, a myristate or a palmitate. When the carbon number is less than 10, the stability at high temperatures is poor, and when it exceeds 16, the stability at low temperatures is poor. The mass ratio of the higher fatty acid salt having a carbon number of 12 or less and the higher fatty acid salt having a carbon number of 14 or more is preferably 80/20 to 40/60, particularly preferably 75/25 to 50/50, and 70/30 to 60/ 40 is better. When the ratio of the higher fatty acid salt having a carbon number of 12 or less exceeds 80/20, the high-temperature stability is poor, and if it is less than 40/60, the low-temperature stability and the solubility in water may be deteriorated.
M(對離子)形成COOM鹽。作為M,就低溫安定性之觀點,以鉀、鈉、單乙醇胺、二乙醇胺、三乙醇胺為宜,就低溫安定性之觀點,以鉀、單乙醇胺尤佳。另外,就殺菌力及低溫安定性之觀點,以高級脂肪酸鹽量為100質量%時,單乙醇胺鹽的比率係以1~35質量%為宜,以3~15質量%尤佳。M (pair of ions) forms a COOM salt. As M, potassium, sodium, monoethanolamine, diethanolamine, and triethanolamine are preferable from the viewpoint of low-temperature stability, and potassium or monoethanolamine is particularly preferable from the viewpoint of low-temperature stability. Further, in view of the sterilizing power and the low-temperature stability, when the amount of the higher fatty acid salt is 100% by mass, the ratio of the monoethanolamine salt is preferably from 1 to 35% by mass, particularly preferably from 3 to 15% by mass.
(A)成份含量於皮膚洗淨劑組成物中為15~45質量%。若未滿15質量%時,不形成液晶。另一方面,若超過45質量%時,於低溫產生析出物。進而,就起泡及低溫安定性之觀點,為17~40質量%,以20~35質量%為宜,以25~35質量%尤佳。The component (A) is 15 to 45% by mass in the skin detergent composition. If it is less than 15% by mass, no liquid crystal is formed. On the other hand, when it exceeds 45 mass%, a precipitate is produced at a low temperature. Further, from the viewpoint of foaming and low-temperature stability, it is preferably from 17 to 40% by mass, preferably from 20 to 35% by mass, particularly preferably from 25 to 35% by mass.
(B)甜菜鹼型兩性界面活性劑(B) Betaine type amphoteric surfactant
作為甜菜鹼型兩性界面活性劑,可舉例如咪唑啉型(醯胺胺(amidoamine)型)、羧基甜菜鹼(carboxybetaine)型、磺基甜菜鹼(sulfobetaine)型、磷酸甜菜鹼(phosphobetaine)型等。此等係可單獨1種或適當組合2種以上使用。就容易形成液晶之觀點,此等中以羧基甜菜鹼型為宜。Examples of the betaine-type amphoteric surfactant include imidazoline type (amidoamine type), carboxybetaine type, sulfobetaine type, phosphobetaine type, and the like. . These may be used alone or in combination of two or more. From the viewpoint of easily forming a liquid crystal, it is preferred to use a carboxybetaine type in these.
作為羧基甜菜鹼型,可舉例如月桂基甜菜鹼、月桂基二甲基胺基醋酸甜菜鹼等之烷基甜菜鹼、月桂酸醯胺丙基甜菜鹼、椰子油脂肪酸醯胺丙基甜菜鹼等之烷基醯胺甜菜鹼等。其中就液晶形成性之觀點,以月桂基二甲基胺基醋酸甜菜鹼、月桂酸醯胺丙基甜菜鹼為宜,尤其就低溫安定性之觀點,以月桂酸醯胺丙基甜菜鹼尤佳。前述兩性界面活性劑於製造步驟中可能含有氯化鈉,就提升低溫安定性之觀點,進行脫鹽處理,前述兩性界面活性劑水溶液中,以氯化鈉為1質量%以下者尤佳。Examples of the carboxybetaine type include alkylbetaine such as lauryl betaine, lauryl dimethylaminoacetate betaine, melamine propyl citrate, coconut fatty acid guanamine propyl betaine, and the like. Alkyl guanamine betaine and the like. Among them, from the viewpoint of liquid crystal formability, it is preferable to use lauryl dimethylaminoacetate acetate betaine or lysine propyl propyl citrate, especially from the viewpoint of low temperature stability, and lysine propyl citrate is preferred. . The amphoteric surfactant may contain sodium chloride in the production step, and desalting treatment is carried out from the viewpoint of improving the low-temperature stability. The aqueous solution of the amphoteric surfactant is preferably 1% by mass or less based on sodium chloride.
(B)成份含量於皮膚洗淨劑組成物中為7~25質量%,以9~15質量%為宜。若未滿7質量%,不形成液晶,若超過25質量%時,則於低溫容易發生析出。The component (B) is 7 to 25% by mass in the skin detergent composition, and preferably 9 to 15% by mass. When it is less than 7% by mass, liquid crystal is not formed, and when it exceeds 25% by mass, precipitation is likely to occur at a low temperature.
(C)下述非離子性界面活性劑(C) The following nonionic surfactants
本發明之(C)成份為聚氧乙烯(環氧乙烷之平均加成莫耳數10~80)甘油酯、甘油、或聚氧乙烯(環氧乙烷之平均加成莫耳數10~80)三羥甲基丙烷的3個羥基經酯化或醚化的化合物,酯化或醚化的部份係碳數7~25的飽和或不飽和,直鏈或支鏈的一價烴基,亦可部份氫原子為羥基所取代,亦可於此羥基加成平均加成莫耳數為10~80之聚氧乙烯,但是,非離子性界面活性劑所加成之聚氧乙烯總數係平均加成莫耳數為10~80。The component (C) of the present invention is a polyoxyethylene (average addition molar number of ethylene oxide of 10 to 80) glyceride, glycerin, or polyoxyethylene (the average addition molar number of ethylene oxide is 10 to 10) 80) a compound in which three hydroxyl groups of trimethylolpropane are esterified or etherified, and the esterified or etherified portion is a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms. Alternatively, some of the hydrogen atoms may be substituted by a hydroxyl group, and the hydroxyl group may be added to form an average of 10 to 80 moles of polyoxyethylene, but the total amount of polyoxyethylene added by the nonionic surfactant is The average addition mole number is 10 to 80.
被酯化或醚化之羥基為2個以下時,對製劑的水的溶解性降低。另外,非離子性界面活性劑所加成之聚氧乙烯總數係以15~40莫耳尤佳。未滿10莫耳時,除了對製劑的水的溶解性或低溫安定性降低以外,可能濁白而失去透明性,若超過80莫耳時,則高溫安定性變差。When the number of hydroxyl groups which are esterified or etherified is two or less, the solubility in water of the preparation is lowered. Further, the total amount of polyoxyethylene added by the nonionic surfactant is preferably from 15 to 40 moles. When it is less than 10 moles, in addition to the solubility in water of the preparation or the low-temperature stability, it may be cloudy and lose transparency, and if it exceeds 80 moles, the high-temperature stability may be deteriorated.
其中,具有下述結構之非離子性界面活性劑(i)~(iii),因為可得到於高溫、低溫保存時之安定性佳,即使手濕的狀態亦有良好的使用性之液晶狀態之皮膚洗淨劑組成物,所以適宜。Among them, the nonionic surfactants (i) to (iii) having the following structure are excellent in stability at high temperature and low temperature storage, and have good usability in liquid crystal state even in a wet state. The skin cleanser composition is suitable.
(i)為聚氧乙烯(環氧乙烷之平均加成莫耳數10~80)甘油酯的3個羥基經酯化或醚化的化合物,酯化或醚化的部份係碳數7~25的飽和或不飽和,直鏈或支鏈的一價烴基,亦可部份氫原子為羥基所取代,亦可於此羥基加成平均加成莫耳數為10~80之聚氧乙烯之非離子性界面活性劑(但是,非離子性界面活性劑所加成之聚氧乙烯總數係平均加成莫耳數為10~80。)。(i) a compound which is esterified or etherified with three hydroxyl groups of polyoxyethylene (average addition molar number of ethylene oxide of 10 to 80), esterified or etherified, carbon number 7 ~25 of a saturated or unsaturated, linear or branched monovalent hydrocarbon group, or a part of a hydrogen atom may be substituted by a hydroxyl group, or an average addition of a hydroxyl group of 10 to 80 polyoxyethylene. The nonionic surfactant (however, the total amount of polyoxyethylene added by the nonionic surfactant is an average addition molar number of 10 to 80.).
符合上述(i)之非離子性界面活性劑,可舉例如三異硬脂酸PEG-20甘油酯、三硬脂酸PEG-20甘油酯、三油酸PEG-20甘油酯等。The nonionic surfactant corresponding to the above (i) may, for example, be PEG-20 glyceryl triisostearate, PEG-20 glyceryl tristearate or PEG-20 glycerol trioleate.
(ii)為甘油的3個羥基經酯化或醚化的化合物,酯化或醚化的部份係碳數7~25的飽和或不飽和,直鏈或支鏈的一價烴基,亦可部份氫原子為羥基所取代,於此羥基加成平均加成莫耳數為10~80之聚氧乙烯之非離子性界面活性劑(但是,非離子性界面活性劑所加成之聚氧乙烯總數係平均加成莫耳數為10~80。)。(ii) a compound which is esterified or etherified with three hydroxyl groups of glycerol. The esterified or etherified moiety is a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms. Part of the hydrogen atom is replaced by a hydroxyl group, and the hydroxyl group is added to form a polyoxyethylene nonionic surfactant having an average molar number of 10 to 80 (however, the polyoxygen added by the nonionic surfactant) The total number of ethylene added is 10 to 80.
符合上述(ii)之非離子性界面活性劑,可舉例如聚氧乙烯氫化萞麻油(E.O.10)、聚氧乙烯萞麻油(E.O.20)、聚氧乙烯氫化萞麻油(E.O.20)、聚氧乙烯氫化萞麻油(E.O.40)、聚氧乙烯萞麻油(E.O.40)、聚氧乙烯氫化萞麻油(E.O.80)等。The nonionic surfactant conforming to the above (ii) may, for example, be polyoxyethylene hydrogenated castor oil (EO10), polyoxyethylene castor oil (EO20), polyoxyethylene hydrogenated castor oil (EO20), polyoxygen Ethylene hydrogenated castor oil (EO40), polyoxyethylene castor oil (EO40), polyoxyethylene hydrogenated castor oil (EO80), and the like.
(iii)為聚氧乙烯(環氧乙烷之平均加成莫耳數10~80)三羥甲基丙烷的3個羥基經酯化或醚化的化合物,酯化或醚化的部份係碳數7~25的飽和或不飽和,直鏈或支鏈的一價烴基,亦可部份氫原子為羥基所取代,亦可於此羥基加成平均加成莫耳數為10~80之聚氧乙烯之非離子性界面活性劑(但是,非離子性界面活性劑所加成之聚氧乙烯總數係平均加成莫耳數為10~80。)(iii) a compound in which esterified or etherified compound is esterified or etherified with polyoxyethylene (average addition molar number of ethylene oxide of 10 to 80) of three hydroxyl groups of trimethylolpropane. a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms, or a partial hydrogen atom may be substituted by a hydroxyl group, or an average addition molar number of 10 to 80 in the hydroxyl group addition. A nonionic surfactant of polyoxyethylene (however, the total amount of polyoxyethylene added by the nonionic surfactant is an average addition mole number of 10 to 80.)
符合上述(iii)之非離子性界面活性劑,可舉例如三異硬脂酸PEG-20三羥甲基丙烷等。The nonionic surfactant corresponding to the above (iii) may, for example, be triisostearic acid PEG-20 trimethylolpropane or the like.
具體上,可舉例如下述者。以下PEG係表示聚乙二醇,POE係表示聚氧乙烯。例如POE(20)係表示聚氧乙烯之平均加成莫耳數為20。Specifically, for example, the following may be mentioned. The following PEG represents polyethylene glycol, and the POE represents polyoxyethylene. For example, POE (20) means that the average addition molar number of polyoxyethylene is 20.
三異硬脂酸PEG-20甘油酯(日本Emulsion,GWIS-320)HLB=8Triisostearic acid PEG-20 glyceride (Japan Emulsion, GWIS-320) HLB=8
三硬脂酸PEG-20甘油酯(日本Emulsion,GWS-320,HLB=8)Tristearate PEG-20 glyceride (Japan Emulsion, GWS-320, HLB=8)
三油酸PEG-20甘油酯(日本Emulsion,GWO-320,HLB=8)Triolein PEG-20 glyceride (Japan Emulsion, GWO-320, HLB=8)
三異硬脂酸PEG-20三羥甲基丙烷(日本Emulsion,TPIS-320,HLB=8)Triisostearic acid PEG-20 trimethylolpropane (Japan Emulsion, TPIS-320, HLB=8)
POE(20)萞麻油(日本Emulsion,C-20,HLB=9)POE (20) castor oil (Japan Emulsion, C-20, HLB=9)
POE(10)氫化萞麻油(日本Emulsion,HC-10,HLB=7)POE (10) hydrogenated castor oil (Japan Emulsion, HC-10, HLB=7)
POE(10)氫化萞麻油(日光Chemicals,HCO-10,HLB=6)POE (10) hydrogenated castor oil (Sunlight Chemicals, HCO-10, HLB=6)
POE(20)氫化萞麻油(日本Emulsion,HC-20,HLB=9)POE (20) hydrogenated castor oil (Japan Emulsion, HC-20, HLB=9)
POE(20)氫化萞麻油(日光Chemicals,HCO-20,HLB=10.5)POE (20) hydrogenated castor oil (Sunlight Chemicals, HCO-20, HLB=10.5)
POE(40)氫化萞麻油(日本Emulsion,HC-40,HLB=12)POE (40) hydrogenated castor oil (Japan Emulsion, HC-40, HLB=12)
POE(40)氫化萞麻油(日光Chemicals,HCO-40,HLB=12.5)POE (40) hydrogenated castor oil (Sunlight Chemicals, HCO-40, HLB = 12.5)
POE(80)氫化萞麻油(日本Emulsion,HC-80,HLB=15)POE (80) hydrogenated castor oil (Japan Emulsion, HC-80, HLB=15)
POE(80)氫化萞麻油(日光Chemicals,HCO-80,HLB=15.0)POE (80) hydrogenated castor oil (Sunlight Chemicals, HCO-80, HLB = 15.0)
酯化或醚化的部份係碳數7~25,以16~20為宜之一價烴基,一價烴基係飽和或不飽和,直鏈或支鏈中任一種皆可,亦可部份氫原子為羥基所取代。就對製劑之水之容易溶解之觀點,以烴支鏈、或烴非末端部份具有羥基之烴鏈尤佳。其中,就對製劑之水容易溶解之觀點,前述符合(ii)之非離子性界面活性劑尤佳,以聚氧乙烯氫化萞麻油、聚氧乙烯萞麻油尤佳。聚氧乙烯萞麻油之經酯化的脂肪酸殘基的部份(合併烴鏈與酯基的部份)係不飽和脂肪酸(87質量%之萞麻酸、7質量%之油酸、3質量%之亞油酸)及少量的飽和脂肪酸(3質量%之棕櫚酸、硬脂酸等),氫化萞麻油時係將前述脂肪酸氫化者。尤其,就對製劑之水容易溶解之觀點,於前述脂肪酸殘基的脂肪酸分佈,以含有80質量%以上之12位具有羥基之萞麻酸、或其氫化物者為宜。The esterified or etherified fraction is a carbon number of 7 to 25, preferably 16 to 20, preferably a monovalent hydrocarbon group, and the monovalent hydrocarbon group is saturated or unsaturated, either linear or branched, or partially The hydrogen atom is replaced by a hydroxyl group. From the viewpoint of easy dissolution of the water of the preparation, a hydrocarbon chain having a hydrocarbon branch or a hydrocarbon having a non-terminal portion is particularly preferable. Among them, in view of the fact that the water of the preparation is easily dissolved, the above-mentioned nonionic surfactant conforming to (ii) is particularly preferable, and polyoxyethylene hydrogenated castor oil and polyoxyethylene castor oil are particularly preferable. The esterified fatty acid residue portion (part of the hydrocarbon chain and the ester group) of the polyoxyethylene castor oil is an unsaturated fatty acid (87% by mass of ricinoleic acid, 7% by mass of oleic acid, and 3% by mass) The linoleic acid) and a small amount of a saturated fatty acid (3 mass% of palmitic acid, stearic acid, etc.), and hydrogenated castor oil are those which hydrogenate the said fatty acid. In particular, in view of the fact that the water of the preparation is easily dissolved, it is preferred that the fatty acid distribution of the fatty acid residue is 80% by mass or more of the ricinic acid having a hydroxyl group at 12 positions or a hydrogenated product thereof.
就可得到於高溫、低溫保存時之安定性佳,即使手濕的狀態亦有良好的使用性之液晶狀態之皮膚洗淨劑組成物之觀點,其中之聚氧乙烯氫化萞麻油(E.O.20)[POE(20)氫化萞麻油]、聚氧乙烯氫化萞麻油(E.O.40)[POE(40)氫化萞麻油]、聚氧乙烯氫化萞麻油(E.O.20)[POE(20)萞麻油]、POE(40)萞麻油[POE(40)氫化萞麻油]最好。該機制不明,但認為POE氫化萞麻油或POE萞麻油係存在於烴基的羥基上聚氧乙烯鏈以支鏈存在之結構而緩和液晶結構。It is excellent in stability at high temperature and low temperature storage, and it has a good usability liquid crystal state of the skin detergent composition even in the case where the hand is wet, and the polyoxyethylene hydrogenated castor oil (EO20) is obtained. [POE (20) hydrogenated castor oil], polyoxyethylene hydrogenated castor oil (EO40) [POE (40) hydrogenated castor oil], polyoxyethylene hydrogenated castor oil (EO20) [POE (20) castor oil], POE (40) Castor oil [POE (40) hydrogenated castor oil] is best. This mechanism is not known, but it is considered that POE hydrogenated castor oil or POE castor oil is present on the hydroxyl group of the hydrocarbon group, and the polyoxyethylene chain is branched to form a structure to relax the liquid crystal structure.
(C)成份含量於皮膚洗淨劑組成物中為1~5質量%,特別是2~4質量%,尤其2~3質量%為宜。未滿1質量%時,對製劑之水之溶解容易度不足,若超過5質量%時,於高溫安定性變差。The component (C) is preferably 1 to 5% by mass, particularly 2 to 4% by mass, particularly preferably 2 to 3% by mass, based on the skin detergent composition. When the amount is less than 1% by mass, the ease of dissolution of water in the preparation is insufficient, and when it exceeds 5% by mass, the stability at high temperature is deteriorated.
(D)多元醇(D) polyol
作為多元醇係以2~6元者為宜,以乙二醇、二乙二醇、聚乙二醇200(醫藥部外用品原料規格2006相當品)、聚乙二醇300(醫藥部外用品原料規格2006相當品)、聚乙二醇400(醫藥部外用品原料規格2006相當品)、聚乙二醇600(醫藥部外用品原料規格2006相當品)、丙二醇、二丙二醇、1,3-丁二醇、異戊基二醇、戊二醇、1,2-己二醇、己二醇、甘油、二甘油、山梨糖醇、木糖醇、甘露醇等為宜,此等係可單獨1種或適當組合2種以上使用。另外,在此所謂聚乙二醇係相當於化妝品原料基準第二版注解、醫藥部外用品原料規格2006,日本藥局方醫藥品規格2002、第15改定日本藥局方所規定者。其中就液晶形成容易度之觀點,以丙二醇、聚乙二醇200、聚乙二醇300、聚乙二醇400、聚乙二醇600、丙二醇、甘油、山梨糖醇為宜。進而,就低溫安定性及容易形成液晶之觀點,以混合2元及3元的多元醇為宜,以丙二醇及甘油的組合尤佳,丙二醇之質量(%)/甘油之質量(%)係以20/80~50/50尤佳。丙二醇的比率若超過50/50時,液晶形成性可能降低,高溫安定性可能降低,若未滿20/80時,黏度可能過高。It is suitable for the polyol to be 2 to 6 yuan, and ethylene glycol, diethylene glycol, polyethylene glycol 200 (the equivalent of the pharmaceutical raw materials specifications 2006), polyethylene glycol 300 (medical department external supplies) Raw material specifications 2006 equivalent), polyethylene glycol 400 (medical department raw materials specifications 2006 equivalent), polyethylene glycol 600 (medical department raw materials specifications 2006 equivalent), propylene glycol, dipropylene glycol, 1,3- Butylene glycol, isoamyl glycol, pentanediol, 1,2-hexanediol, hexanediol, glycerin, diglycerin, sorbitol, xylitol, mannitol, etc. are suitable. One type or two or more types may be used in combination as appropriate. In addition, the polyethylene glycol system is equivalent to the second edition of the cosmetic raw material reference, the pharmaceutical raw material raw material specification 2006, the Japanese Pharmacy Pharmaceutical Standard 2002, and the 15th revised Japanese Pharmacopoeia. Among them, propylene glycol, polyethylene glycol 200, polyethylene glycol 300, polyethylene glycol 400, polyethylene glycol 600, propylene glycol, glycerin, and sorbitol are preferred from the viewpoint of easiness of liquid crystal formation. Further, from the viewpoints of low-temperature stability and easy formation of liquid crystal, it is preferred to mix a divalent or trivalent polyol, preferably a combination of propylene glycol and glycerin, and the mass (%) of propylene glycol/mass (%) of glycerol is 20/80~50/50 is especially good. When the ratio of propylene glycol exceeds 50/50, the liquid crystal formability may be lowered, and the high temperature stability may be lowered. If it is less than 20/80, the viscosity may be too high.
(D)成份含量於皮膚洗淨劑組成物中為15~35質量%,以20~30質量%為宜。若未滿15質量%時,低溫安定性差,若超過35質量%時,變得難以形成液晶。The component (D) is 15 to 35 mass% in the skin detergent composition, and preferably 20 to 30 mass%. When it is less than 15% by mass, the low-temperature stability is poor, and when it exceeds 35% by mass, it becomes difficult to form a liquid crystal.
(A)高級脂肪酸鹽與(B)甜菜鹼型兩性界面活性劑之質量比係以85/15~60/40為宜。(A)成份比若超過85/15時,有低溫之安定性變差之虞,若未滿60/40,沖洗時會發生黏膩感。The mass ratio of (A) the higher fatty acid salt to the (B) betaine type amphoteric surfactant is preferably from 85/15 to 60/40. (A) If the composition ratio exceeds 85/15, the stability of low temperature deteriorates. If it is less than 60/40, a sticky feeling will occur when washing.
(A)高級脂肪酸鹽與(D)多元醇之質量比係以70/30~40/60為宜。(A)成份比若超過70/30時,低溫之安定性可能變差,若未滿40/60時,有高溫安定性及透明度降低之虞。The mass ratio of (A) the higher fatty acid salt to the (D) polyol is preferably from 70/30 to 40/60. (A) When the composition ratio exceeds 70/30, the stability of low temperature may be deteriorated. If it is less than 40/60, the stability of high temperature and the decrease in transparency may occur.
本發明之皮膚洗淨劑組成物於25℃時為液晶狀態。本發明中所謂的液晶係指六角(hexagonal)液晶、層狀(lamellar)液晶、立方(cubic)液晶。就使用性、具有透明外觀之觀點,其中以六角液晶為宜。因為層狀液晶黏度低,使用時自手垂落、或因添加的水而增黏,所以有使用性變差之虞。The skin cleansing composition of the present invention is in a liquid crystal state at 25 °C. The liquid crystal in the present invention means a hexagonal liquid crystal, a lamellar liquid crystal, or a cubic liquid crystal. In terms of usability and a transparent appearance, hexagonal liquid crystals are preferred. Since the lamellar liquid crystal has a low viscosity, it is dripped by hand or thickened by the added water during use, so that the usability is deteriorated.
另外,本發明中所謂「液晶」係指界面活性劑之分子聚合物,藉由高濃度或具有相異電荷之離子性高分子化合物的存在,圓筒型之界面活性劑成為棒狀分子之液晶狀態。如此的基於液晶表示此定向秩序之各向異性係來自分子形狀或分子間力量之「自發性」,非因任何外力所引發的。高分子化合物之濃厚溶液,若使流動時則發生分子定向,可見到光學的各向異性,但若停止流動時,如此的定向非自發的。就兼具所謂流動性之液體特性與所謂光學各異向性之液晶特性之觀點,液晶係極為特異的狀態,不能分類於固體或異體,因此認為係物質的「第4狀態」。Further, the term "liquid crystal" as used in the present invention means a molecular polymer of a surfactant, and a cylindrical surfactant becomes a liquid crystal of a rod-shaped molecule by the presence of a high concentration or an ionic polymer compound having a different charge. status. Such anisotropy based on liquid crystals indicates that the orientation of the orientation is derived from the "spontaneity" of molecular shape or intermolecular forces, and is not caused by any external force. In the thick solution of the polymer compound, if the molecular orientation occurs when flowing, optical anisotropy can be seen, but if the flow is stopped, such orientation is not spontaneous. From the viewpoint of the liquid property of the so-called fluidity and the liquid crystal characteristics of the optical anisotropy, the liquid crystal system is extremely specific and cannot be classified into a solid or a foreign body. Therefore, the "fourth state" of the substance is considered.
確認「液晶狀態」係可由偏光顯微鏡觀察干涉條紋而判斷。觀察到干涉條紋為魚鱗狀之鑲嵌結構(mosaic texture)時為六角液晶,觀察到十字模樣之正交偏光(cross nicol)時為層狀液晶,未見有干涉條紋時為微膠團型(micelle相)、或立方液晶相。此等典型的干涉條紋係舉例於R. B. Rosevere,“The microscopy of the Liquid Crystalline Neat and Middle Phase of soaps and synthetic detergents”J. Am. Oil Chemist’s Soc.,628,31(1954)。另外,於25℃所見為固形物時,即使看到此等之干涉條紋,仍不能判斷為液晶相。另一方面,黏性非常高,未見有干涉條紋之立方層之判定或難以偏光顯微鏡判斷時,可由小角度X光散射(small angle X-ray scattering)之干涉模式判斷。對應於(100),(110),(200)面,對應1:√3:2:‧‧‧之晶面間距比之散射角出現波峰者為六角液晶相,對應於(100)、(200)、(300)面,對應1:2:3:‧‧‧之晶面間距比之散射角出現波峰者為層狀液晶相,對應於(100)、(111)、(200)面之晶面間距1:√3/2:√2:‧‧‧,或對應於(211)、(220)、(321)、(400)面之1:√4/3:√7/3:√8/3:‧‧‧出現波峰者為立方液晶相。另外,小角度部份之X光散射未見有明確的波峰,散射向量q=0.1~0.5nm-1附近,見有寬廣波峰時為微膠團型。It is confirmed that the "liquid crystal state" can be judged by observing interference fringes by a polarizing microscope. Hexagonal liquid crystal was observed when the interference fringe was a fish scale-like mosaic texture, and lamellar liquid crystal was observed when a cross-type cross-crossing was observed. When no interference fringes were observed, it was a micro-micelle type (micelle). Phase), or cubic liquid crystal phase. Such typical interference fringes are exemplified in RB Rosevere, "The microscopy of the Liquid Crystalline Neat and Middle Phase of soaps and synthetic detergents" J. Am. Oil Chemist's Soc., 628, 31 (1954). Further, when a solid matter was observed at 25 ° C, even if such interference fringes were observed, it was not possible to judge the liquid crystal phase. On the other hand, the viscosity is very high, and when no cubic layer of interference fringes is judged or it is difficult to determine by a polarizing microscope, it can be judged by the interference mode of small angle X-ray scattering. Corresponding to (100), (110), (200) faces, corresponding to 1:3:2:‧‧‧ The interplanar spacing ratio is the hexagonal liquid crystal phase, which corresponds to (100), (200) ), (300) plane, corresponding to the 1:2:3: ‧ ‧ the plane spacing ratio of the scattering angle appears as a layered liquid crystal phase, corresponding to the (100), (111), (200) surface crystal Face spacing 1: √3/2: √2: ‧‧‧, or corresponding to (211), (220), (321), (400) face 1: √ 4/3: √ 7/3: √ 8 /3:‧‧‧ The peak appears as a cubic liquid crystal phase. In addition, there is no clear peak in the X-ray scattering of the small-angle portion, and the scattering vector q is near 0.1 to 0.5 nm -1 , and when there is a broad peak, it is a micro-micelle type.
另外,就外觀美觀等,皮膚洗淨劑組合物係以透明為宜。另外,所謂「透明」係指於後述實施例之<透明度>測定中,評估基準為「◎」、「○」。於後述實施例之<透明度>測定中,為得到透明度◎之「透明」組成物,(A)~(D)成份係以滿足下述條件為宜。Further, in terms of aesthetic appearance and the like, the skin detergent composition is preferably transparent. In addition, "transparency" means that the evaluation criteria are "◎" and "○" in the <transparency> measurement of the embodiment described later. In the "transparency" measurement of the examples described later, in order to obtain a "transparent" composition of transparency ◎, the components (A) to (D) are preferably satisfying the following conditions.
(A)成份含量於皮膚洗淨劑組成物中為20~35質量%,碳數為12以下之高級脂肪酸鹽及碳數14以上的高級脂肪酸鹽的質量比係80/20~50/50。(A) The content of the component is 20 to 35 mass% in the skin detergent composition, and the mass ratio of the higher fatty acid salt having a carbon number of 12 or less and the higher fatty acid salt having a carbon number of 14 or more is 80/20 to 50/50.
(B)成份為月桂基二甲基胺基醋酸甜菜鹼,其含量於皮膚洗淨劑組成物中為7~15質量%。The component (B) is lauryl dimethylaminoacetate betaine, and the content thereof is 7 to 15% by mass in the skin detergent composition.
(C)成份係選自三異硬脂酸PEG-20甘油酯、三油酸PEG-20甘油酯、三異硬脂酸PEG-20三羥甲基丙烷、POE(20~80)氫化萞麻油及POE(20~80)萞麻油,其含量於皮膚洗淨劑組成物中為2~5質量%。The component (C) is selected from the group consisting of PEG-20 glyceryl triisostearate, PEG-20 glycerol trioleate, PEG-20 trimethylolpropane triisostearate, and POE (20-80) hydrogenated castor oil. And POE (20-80) castor oil, the content of which is 2 to 5% by mass in the skin detergent composition.
(D)成份係併用丙二醇及甘油、丙二醇或聚乙二醇400,其含量於皮膚洗淨劑組成物中為25~35質量%,併用丙二醇及甘油時,丙二醇之比率為20/80以上。(D) The component is a combination of propylene glycol, glycerin, propylene glycol or polyethylene glycol 400 in an amount of 25 to 35% by mass in the skin detergent composition, and when propylene glycol and glycerin are used, the ratio of propylene glycol is 20/80 or more.
本發明之皮膚洗淨劑組成物係於不妨礙本發明目的之範圍,可摻合適當選擇之其他成份。作為其他成份,可自皮膚洗淨劑組成物通常使用物中適當選擇,例如油分、聚矽氧烷類、低級或高級醇等之醇類、含水羊毛脂衍生物、蛋白衍生物、丙烯酸樹脂分散液、維生素等之藥劑、殺菌劑、防腐劑、氫氧化鉀、檸檬酸等之pH調整劑、抗氧化劑、金屬封鎖劑、紫外線吸收劑、動植物萃取物或其衍生物、色素、香料、顏料、無機粉體、黏土礦物、尼龍、聚乙烯等之水不溶性之聚合物粉體等。The skin cleansing composition of the present invention may be incorporated into other ingredients which are suitably selected, without departing from the scope of the present invention. As the other ingredients, it can be appropriately selected from the usual use of the skin detergent composition, for example, an oil such as an oil, a polyoxyalkylene, a lower or higher alcohol, an aqueous lanolin derivative, a protein derivative, or an acrylic resin dispersion. Liquid, vitamins, etc., bactericides, preservatives, pH adjusters such as potassium hydroxide and citric acid, antioxidants, metal blocking agents, ultraviolet absorbers, animal and plant extracts or derivatives thereof, pigments, perfumes, pigments, Water-insoluble polymer powders such as inorganic powders, clay minerals, nylons, and polyethylenes.
本發明之皮膚洗淨劑組成物之pH,就低溫安定性或液晶形成性面上,以9.0~11.0為宜,就低溫安定性之觀點,以9.4~10.6尤佳。若pH未滿9.0時,低溫安定性可能變差,若超過11.0時,可能變得難以形成液晶。The pH of the skin detergent composition of the present invention is preferably 9.0 to 11.0 on the low-temperature stability or liquid crystal-forming surface, and particularly preferably 9.4 to 10.6 from the viewpoint of low-temperature stability. When the pH is less than 9.0, the low-temperature stability may be deteriorated, and if it exceeds 11.0, it may become difficult to form a liquid crystal.
本發明之皮膚洗淨劑組成物之黏度,於25℃為20~500Pa‧s為宜,以130~350Pa‧s尤佳。未滿20Pa‧s時,有高溫安定性變差之虞,若超過500Pa‧s時,有時對製劑之水之溶解性變差。另外,黏度係使用BH型黏度計(東京計器股份有限公司製),測定樣品溫度25℃,轉輪No.7,旋轉次數4rpm,1分鐘後之黏度。The viscosity of the skin detergent composition of the present invention is preferably from 20 to 500 Pa s at 25 ° C, particularly preferably from 130 to 350 Pa ‧ s. When the temperature is less than 20 Pa ‧ , the stability of the high temperature is deteriorated. If it exceeds 500 Pa ‧ , the solubility in the water of the preparation may be deteriorated. In addition, the viscosity was measured using a BH-type viscometer (manufactured by Tokyo Keiki Co., Ltd.), and the sample temperature was 25 ° C, the number of revolutions No. 7, the number of rotations of 4 rpm, and the viscosity after one minute.
本發明之皮膚洗淨劑組成物亦可使用臉部用、身體用,只要是皮膚,其對象並無特別限制。The skin detergent composition of the present invention can also be used for the face or the body, and the object is not particularly limited as long as it is skin.
實施例Example
以下係表示實施例及比較例,具體地說明本發明,但本發明並不局限於下述實施例。另外,下述例中,除非特別記述以外,組成之「%」為質量%,比率係表示質量比,表中各成份的量係純份量換算的量。Hereinafter, the present invention will be specifically described by way of examples and comparative examples, but the present invention is not limited to the following examples. In the following examples, unless otherwise specified, the "%" of the composition is % by mass, and the ratio is the mass ratio, and the amount of each component in the table is the amount converted by the pure amount.
[實施例1~38,比較例1~12][Examples 1 to 38, Comparative Examples 1 to 12]
如下述調製皮膚洗淨劑組成物。秤取(A)、(C)、(D)成份及精製水於真空乳化釜之容器。於減壓狀態,加熱成80℃溶解。溶解後,槳狀攪拌下,加入(B)成份溶解,於減壓狀態以1℃/分,冷卻至35℃,充份地進行減壓、攪拌後脫氣。脫氣後,以1℃/分,冷卻至25℃。接著,使用酸鹼度計HM-30R(東亞DKK股份有限公司製)測定pH,使用氫氧化鉀或檸檬酸,調整成目標pH。pH係測定漬浸電極於25℃之樣品2分鐘後之值。對所得之皮膚洗淨劑組成物,進行下述評估。結果合記於表中。The skin cleanser composition was prepared as follows. Weigh (A), (C), (D) components and purified water in a container of a vacuum emulsification kettle. In a reduced pressure state, it was dissolved at 80 ° C by heating. After the dissolution, the component (B) was dissolved in a paddle stirring, and the mixture was cooled to 35 ° C at a reduced pressure of 1 ° C / min, and the mixture was thoroughly depressurized, stirred, and then degassed. After degassing, it was cooled to 25 ° C at 1 ° C / min. Next, the pH was measured using a pH meter HM-30R (manufactured by Toa DKK Co., Ltd.), and adjusted to a target pH using potassium hydroxide or citric acid. The pH was measured after the sample was immersed in the sample at 25 ° C for 2 minutes. The obtained skin detergent composition was evaluated as follows. The results are recorded in the table.
<黏度><viscosity>
使用BH型黏度計(東京計器製股份有限公司),測定樣品溫度25℃,轉輪No.7,旋轉次數4rpm,1分鐘後之黏度。The viscosity of the sample was measured at 25 ° C, the rotor No. 7, the number of rotations of 4 rpm, and the viscosity after 1 minute using a BH type viscometer (Tokyo Keiki Co., Ltd.).
<確認液晶狀態><Confirm LCD status>
確認液晶狀態係使皮膚洗淨劑組成物成25℃,使用偏光顯微鏡AX70(Olympus(股))進行觀察。觀察到干涉條紋為魚鱗狀之鑲嵌結構時為六角液晶,觀察到十字模樣之正交偏光(cross nicol)時為層狀液晶,未見有干涉條紋時為微膠團型(micelle相)。本發明之液晶係指六角液晶、層狀液晶、立方液晶。此等典型的干涉條紋係舉例於R. B. Rosevere,“The microscopy of the Liquid Crystalline Neat and Middle Phase of soaps and synthetic detergents”J. Am. Oil Chemist’s Soc.,628,31(1954)等。另外,於25℃見到固形物分散時,即使看到此等的干涉條紋,仍不能判斷為液晶相。The liquid crystal state was confirmed to be 25 ° C in the skin detergent composition, and observed using a polarizing microscope AX70 (Olympus). It was observed that the interference fringe was a hexagonal liquid crystal when it was a fish scale-like mosaic structure, and it was a lamellar liquid crystal when a cross nicol of a cross pattern was observed, and a micro-micelle type (micelle phase) when no interference fringe was observed. The liquid crystal of the present invention means a hexagonal liquid crystal, a layered liquid crystal, or a cubic liquid crystal. Such typical interference fringes are exemplified in RB Rosevere, "The microscopy of the Liquid Crystalline Neat and Middle Phase of soaps and synthetic detergents" J. Am. Oil Chemist's Soc., 628, 31 (1954) and the like. Further, when the solid matter dispersion was observed at 25 ° C, even if such interference fringes were observed, the liquid crystal phase could not be judged.
另一方面,黏性非常高,未見有干涉條紋的立方液晶層之判定或難以偏光顯微鏡判斷時,使用安裝小角度用受光組與X光聚光鏡之X光繞射裝置X’ Pert Pro(PANalitical社),由小角度X光散射之干涉模式判斷。對應於(100),(110),(200)面,對應1:√3:2:‧‧‧之晶面間距比之散射角出現波峰者為六角液晶相,對應於(100)、(200)、(300)面,對應1:2:3:‧‧‧之晶面間距比之散射角出現波峰者為層狀液晶相,對應於(100)、(111)、(200)面之晶面間距1:√3/2:√2:‧‧‧,或對應於(211)、(220)、(321)、(400)面之1:√4/3:√7/3:√8/3:‧‧‧出現波峰者為立方液晶相。另外,小角度部份之X光散射未見有明確的波峰,散射向量q=0.1~0.5nm-1附近,見有寬廣波峰時為微膠團型。表中係以下述記號表示。On the other hand, when the viscosity is very high, and the cubic liquid crystal layer having interference fringes is not judged or difficult to be judged by a polarizing microscope, the X-ray diffraction device X' Pert Pro (PANalitical) for mounting the small-angle light receiving group and the X-ray condenser is used. (Social), judged by the interference mode of small-angle X-ray scattering. Corresponding to (100), (110), (200) faces, corresponding to 1:3:2:‧‧‧ The interplanar spacing ratio is the hexagonal liquid crystal phase, which corresponds to (100), (200) ), (300) plane, corresponding to the 1:2:3: ‧ ‧ the plane spacing ratio of the scattering angle appears as a layered liquid crystal phase, corresponding to the (100), (111), (200) surface crystal Face spacing 1: √3/2: √2: ‧‧‧, or corresponding to (211), (220), (321), (400) face 1: √ 4/3: √ 7/3: √ 8 /3:‧‧‧ The peak appears as a cubic liquid crystal phase. In addition, there is no clear peak in the X-ray scattering of the small-angle portion, and the scattering vector q is near 0.1 to 0.5 nm -1 , and when there is a broad peak, it is a micro-micelle type. The table is indicated by the following symbols.
層狀液晶:LLayered liquid crystal: L
立方液晶:CCubic LCD: C
六角液晶:HHexagonal liquid crystal: H
微膠團型:MMicro-micule type: M
固體分散:SSolid dispersion: S
<高溫、低溫安定性><High temperature, low temperature stability>
於高度為8cm,口徑為3cm之硬質透明玻璃瓶(容量為55ml),填充50ml之皮膚洗淨劑組成物,於50℃、0℃之各環境下保存,觀察於各保存溫度時的外觀,基於下述判斷基準,評估皮膚洗淨劑組成物之安定性。A hard transparent glass bottle (capacity: 55 ml) having a height of 8 cm and a diameter of 3 cm was filled with 50 ml of a skin detergent composition, and stored at 50 ° C and 0 ° C in each environment to observe the appearance at each storage temperature. The stability of the skin detergent composition was evaluated based on the following criteria.
[判斷基準][Judgement benchmark]
◎:保存4週後,無相分離或析出物,為透明,均勻的狀態。◎: After 4 weeks of storage, there was no phase separation or precipitate, and it was in a transparent and uniform state.
◎~○:保存4週後,雖無相分離或析出物,但看到有部份外觀有些許混濁。◎~○: After 4 weeks of storage, although there was no phase separation or precipitate, some of the appearance was slightly turbid.
○:保存4週後,雖無相分離或析出物,但看到外觀均勻地些許混濁。○: After 4 weeks of storage, although there was no phase separation or precipitate, the appearance was observed to be slightly turbid.
△:保存2週後,雖無相分離或析出物,但保存4週後,相分離或有析出物。△: After 2 weeks of storage, there was no phase separation or precipitate, but after 4 weeks of storage, the phases were separated or precipitated.
×:保存2週後,相分離或有析出物。×: After 2 weeks of storage, the phases were separated or precipitated.
<透明度><transparency>
於高度為8cm,口徑為3cm之硬質透明玻璃瓶(容量為55ml),填充50ml(高度6cm)之皮膚洗淨劑組成物,於25℃之環境下保存1天。於印刷MS角圓體(Gothic)「」的紙上,放置填充各樣品之前述玻璃瓶,基於下述判斷基準,由玻璃瓶上方印刷文字之判別性,評估皮膚洗淨劑組成物之透明度。A hard transparent glass bottle (capacity: 55 ml) having a height of 8 cm and a diameter of 3 cm was filled with a 50 ml (height 6 cm) skin detergent composition and stored at 25 ° C for 1 day. For printing MS corners (Gothic) On the paper, the glass bottle filled with each sample was placed, and the transparency of the skin detergent composition was evaluated based on the discriminability of the printed characters on the top of the glass bottle based on the following criteria.
[判斷基準][Judgement benchmark]
◎:可明確地判別以MS角圓體20pt印刷的「」。◎: It is possible to clearly discriminate the print with the MS angle round body 20pt" "."
○:以MS角圓體20pt印刷「」雖有點模糊,但仍可判別。○: Printed in MS angle round body 20pt" Although it is a bit fuzzy, it can still be judged.
△:雖不能判別以MS角圓體20pt印刷的「」,但可判別以24pt印刷的「」。△: Although it is impossible to discriminate the print with the MS angle round body 20pt" "But it can be judged to be printed at 24pt" "."
×:不能判別以MS角圓體24pt印刷的「」。×: It is impossible to discriminate "200pt printed with MS angle round body" "."
<使用時之溶解容易度><Ease of dissolution at the time of use>
使用時皮膚洗淨劑組成物之溶解容易度係由10位專業評估員使用皮膚洗淨劑組成物進行評估。填充皮膚洗淨劑組成物於管狀容器(直徑3cm,高度8cm,口徑5mm),以水沾濕手心,取各樣品1g,兩手搓揉起泡,評估溶解容易度。評估係基於下述所示之判定基準,給予5階段評分,採取各樣品之評分平均值,由平均值基於下述基準進行。The ease of dissolution of the skin cleanser composition at the time of use was evaluated by 10 professional assessors using a skin cleanser composition. The skin detergent composition was filled in a tubular container (diameter: 3 cm, height: 8 cm, caliber: 5 mm), and the palm of the hand was wet with water, and 1 g of each sample was taken, and both hands were foamed to evaluate ease of dissolution. The evaluation was based on the criteria shown below, and a 5-stage score was given, and the average value of the scores of each sample was taken, and the average value was based on the following criteria.
[判斷基準][Judgement benchmark]
5分:開始搓揉手心的同時,樣品溶解,起泡。5 points: At the same time as the palm of the hand began, the sample dissolved and foamed.
4分:開始搓揉手心2~3次,樣品溶解,起泡。4 points: Start the palm of your hand 2 to 3 times, the sample dissolves and foams.
3分:開始搓揉手心4~7次,樣品溶解,起泡。3 points: Start the palm of your hand 4 to 7 times, the sample dissolves and foams.
2分:開始搓揉手心8~12次,樣品溶解,起泡。2 points: Start the palm of your hand 8 to 12 times, the sample dissolves and foams.
1分:樣品劑自手中滑落、或樣品附著於手心或手指,即使搓揉手心13次以上,亦不能起泡。1 point: The sample agent slips from the hand, or the sample adheres to the palm or the finger. Even if the palm is more than 13 times, it cannot be foamed.
[評分平均值之基準][Base of rating average]
◎:4.5分~5分◎: 4.5 minutes to 5 minutes
◎~○:4.0分~未滿4.5分◎~○: 4.0 points to less than 4.5 points
○:3.0分~未滿4.0分○: 3.0 minutes to less than 4.0 minutes
△:2.0分~未滿3.0分△: 2.0 minutes - less than 3.0 minutes
×:未滿2分×: less than 2 points
另外,為確認本發明之皮膚洗淨劑組成物之殺菌力,對於實施例1、36,進行下述殺菌力試驗。Further, in order to confirm the sterilizing power of the skin detergent composition of the present invention, the following bactericidal power tests were carried out for Examples 1 and 36.
<殺菌力><bactericidal power>
(1)菌液之調製(1) Modulation of bacterial liquid
調製下述菌液,使起始菌數為108個/ml。The following bacterial solution was prepared so that the number of starting bacteria was 10 8 /ml.
金黃色葡萄球菌:Staphylococcus aureus ATCC6538Staphylococcus aureus: Staphylococcus aureus ATCC6538
(2)試驗液(2) Test solution
將實施例1、36所得之皮膚洗淨劑組成物,以自來水稀釋成5倍,調製試驗液。The skin detergent compositions obtained in Examples 1 and 36 were diluted 5 times with tap water to prepare a test solution.
<殺菌力試驗法><Bactericidal test method>
於25℃,添加1ml菌液於9ml試驗液,充份攪拌,添加1分鐘後,加入於4.5ml之SCDLP培養基(Soybean-Casein Digest Broth with Lectin & Polysorbate 80:和光純藥工業(股)製),作為10倍稀釋液。重複相同的方法,得到各稀釋液。自各稀釋液採取1.0ml於培養皿,加入15ml之SCDLP瓊脂培養基(Soybean-Casein Digest Ager with Lectin & Polysorbate 80:和光純藥工業(股)製),使均勻,培養2天(瓊脂平板稀釋法),計數菌落,測定生存菌數。由起始菌數與生存菌數,基於下式算出殺菌力,以下述評估基準評估殺菌效果。1 ml of the bacterial solution was added to 9 ml of the test solution at 25 ° C, and the mixture was stirred for 1 minute, and then added to 4.5 ml of SCDLP medium (Soybean-Casein Digest Broth with Lectin & Polysorbate 80: manufactured by Wako Pure Chemical Industries, Ltd.). , as a 10-fold dilution. The same procedure was repeated to obtain each dilution. 1.0 ml of each dilution was taken in a Petri dish, and 15 ml of SCDLP agar medium (Soybean-Casein Digest Ager with Lectin & Polysorbate 80: manufactured by Wako Pure Chemical Industries, Ltd.) was added to homogenize and culture for 2 days (agar plate dilution method). Count colonies and determine the number of viable cells. The bactericidal power was calculated from the number of starting bacteria and the number of viable cells based on the following formula, and the bactericidal effect was evaluated by the following evaluation criteria.
殺菌力=log(生存菌數/起始菌數)Bactericidal power = log (number of viable cells / number of starting bacteria)
另外,殺菌力係數值愈小,效果愈高。In addition, the smaller the bactericidal force coefficient value, the higher the effect.
實施例1之殺菌力係「-1,1」,實施例36之殺菌力係「-3,2」,確認使用單乙醇胺鹽為(A)成分,殺菌力提升。另外,實施例36係低溫安定性(-5℃,一個月)為「◎」,係低溫安定性佳者。The sterilizing power of Example 1 was "-1, 1", and the sterilizing power of Example 36 was "-3, 2". It was confirmed that the monoethanolamine salt was used as the component (A), and the sterilizing power was improved. Further, in Example 36, the low-temperature stability (-5 ° C, one month) was "◎", and the low-temperature stability was good.
[實施例39][Example 39]
如下述調製皮膚洗淨劑組成物。秤取月桂基二甲基胺基醋酸甜菜鹼及香料以外之共同成份於真空乳化釜之容器。於減壓狀態,加熱成80℃溶解。溶解後,槳狀攪拌下,加入月桂基二甲基胺基醋酸甜菜鹼溶解,於減壓狀態以1℃/分,冷卻至35℃。此刻充份地進行減壓、攪拌後脫氣。脫氣後,添加香料,以1℃/分,冷卻至25℃。接著,使用酸鹼度計HM-30R(東亞DKK股份有限公司製)測定pH,使用氫氧化鉀或檸檬酸,調整成目標pH。The skin cleanser composition was prepared as follows. The common ingredients other than lauryl dimethylaminoacetate acetate and betaine were weighed into a container of a vacuum emulsification kettle. In a reduced pressure state, it was dissolved at 80 ° C by heating. After dissolving, the mixture was dissolved in lauryl dimethylaminoacetic acid betaine by stirring under a paddle, and cooled to 35 ° C at a reduced pressure of 1 ° C / min. At this moment, the pressure was reduced, stirred, and degassed. After degassing, the perfume was added and cooled to 25 ° C at 1 ° C / min. Next, the pH was measured using a pH meter HM-30R (manufactured by Toa DKK Co., Ltd.), and adjusted to a target pH using potassium hydroxide or citric acid.
以氫氧化鉀(48%)或檸檬酸調整成pH10.2。It was adjusted to pH 10.2 with potassium hydroxide (48%) or citric acid.
<評估結果><evaluation result>
黏度:118Pa‧sViscosity: 118Pa‧s
透明度:◎Transparency: ◎
結晶相:HCrystalline phase: H
安定性(50℃):◎Stability (50 ° C): ◎
安定性(0℃):◎Stability (0 ° C): ◎
安定性(-5℃):◎Stability (-5 ° C): ◎
調製實施例及比較例時使用的原料如下所示。The materials used in the preparation of the examples and comparative examples are as follows.
*1:AMOGEN SH(第一工業製藥)*1: AMOGEN SH (First Industrial Pharmaceuticals)
*2:取AMOGEN SH於不銹鋼盤,於真空乾燥機(40℃)乾燥,濃縮成純份量為80%者。*2: AMOGEN SH was taken in a stainless steel pan, dried in a vacuum dryer (40 ° C), and concentrated to a pure fraction of 80%.
* 3:LPB-R(一方社油脂工業) * 3: LPB-R (one company oil industry)
* 4:EMALEX GWIS-320(日本Emulsion,HLB=8) * 4: EMALEX GWIS-320 (Japan Emulsion, HLB=8)
* 5:GWS-320(日本Emulsion,HLB=8) * 5: GWS-320 (Japan Emulsion, HLB=8)
* 6:GWO-320(日本Emulsion,HLB=8) * 6: GWO-320 (Japan Emulsion, HLB=8)
* 7:TPIS-320(日本Emulsion,HLB=8) * 7: TPIS-320 (Japan Emulsion, HLB=8)
* 8:C-20(日本Emulsion,HLB=9) * 8: C-20 (Japan Emulsion, HLB=9)
* 9:HC-10(日本Emulsion,HLB=7) * 9: HC-10 (Japan Emulsion, HLB=7)
* 10:HC-20(日本Emulsion,HLB=9) * 10: HC-20 (Japan Emulsion, HLB=9)
* 11:HC-40(日本Emulsion,HLB=12) * 11: HC-40 (Japan Emulsion, HLB=12)
* 12:HC-80(日本Emulsion,HLB=15) * 12: HC-80 (Japan Emulsion, HLB=15)
* 13:PEG # 400K(Lion) * 13: PEG # 400K (Lion)
* 14:NEOSORB70/02SB(Rocket Japan) * 14: NEOSORB70/02SB (Rocket Japan)
* 15:HC-5(日本Emulsion,HLB=5) * 15: HC-5 (Japan Emulsion, HLB=5)
* 16:HC-100(日本Emulsion,HLB=15) * 16:HC-100 (Japan Emulsion, HLB=15)
* 17:GWIS-220EX(日本Emulsion,HLB=10) * 17: GWIS-220EX (Japan Emulsion, HLB=10)
* 18:GWIS-120(日本Emulsion,HLB=13) * 18: GWIS-120 (Japan Emulsion, HLB=13)
* 19:IPMP(大阪化成) * 19: IPMP (Osaka Chemical)
* 20:dl-α生育醇(DSM Nutrition Japan) * 20: dl-alpha tocopherol (DSM Nutrition Japan)
* 21:FLO-BEADS CL-8007(住友精化) * 21: FLO-BEADS CL-8007 (Sumitomo Refined)
* 22:化妝品用濃甘油 * 22: Concentrated glycerin for cosmetics
Claims (10)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010210990 | 2010-09-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201302226A TW201302226A (en) | 2013-01-16 |
TWI515013B true TWI515013B (en) | 2016-01-01 |
Family
ID=45873837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW100133957A TWI515013B (en) | 2010-09-21 | 2011-09-21 | Skin detergent composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5861639B2 (en) |
KR (1) | KR101790822B1 (en) |
TW (1) | TWI515013B (en) |
WO (1) | WO2012039350A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102099325B1 (en) * | 2014-11-24 | 2020-04-09 | 주식회사 엘지생활건강 | Skin cleansing composition |
WO2021078412A1 (en) * | 2019-10-21 | 2021-04-29 | Jallal Messadek | Fractal formulations |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6357699A (en) * | 1986-08-28 | 1988-03-12 | 株式会社資生堂 | Transparent gel like composition |
JPH01151510A (en) * | 1987-12-09 | 1989-06-14 | Lion Corp | Detergent composition |
JP3216848B2 (en) * | 1993-06-18 | 2001-10-09 | 株式会社資生堂 | Detergent composition |
JPH07215841A (en) * | 1994-01-31 | 1995-08-15 | Shiseido Co Ltd | Skin-cleansing agent |
JPH09279192A (en) * | 1996-04-09 | 1997-10-28 | Nof Corp | Transparent gel-like cleansing agent composition |
JP2005008682A (en) * | 2003-06-17 | 2005-01-13 | Pola Chem Ind Inc | Cream-like detergent |
JP4667164B2 (en) * | 2005-08-12 | 2011-04-06 | 花王株式会社 | Transparent gel detergent composition |
JP3961554B1 (en) * | 2005-10-31 | 2007-08-22 | 花王株式会社 | Thickening and foaming agent |
JP2007169248A (en) * | 2005-12-26 | 2007-07-05 | Lion Corp | Liquid skin cleanser composition |
JP4692358B2 (en) | 2006-03-31 | 2011-06-01 | 日油株式会社 | Hot cleansing fee |
JP4953695B2 (en) * | 2006-06-08 | 2012-06-13 | 株式会社 資生堂 | Transparent liquid cleaning material |
JP5153352B2 (en) * | 2008-01-18 | 2013-02-27 | 小林製薬株式会社 | Cleansing cosmetic composition |
-
2011
- 2011-09-16 JP JP2012535019A patent/JP5861639B2/en active Active
- 2011-09-16 WO PCT/JP2011/071189 patent/WO2012039350A1/en active Application Filing
- 2011-09-16 KR KR1020137006662A patent/KR101790822B1/en active IP Right Grant
- 2011-09-21 TW TW100133957A patent/TWI515013B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2012039350A1 (en) | 2012-03-29 |
KR101790822B1 (en) | 2017-11-20 |
JPWO2012039350A1 (en) | 2014-02-03 |
TW201302226A (en) | 2013-01-16 |
KR20130110157A (en) | 2013-10-08 |
JP5861639B2 (en) | 2016-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101517060B (en) | Structured surfactant system | |
JP4558098B2 (en) | Hair conditioner composition | |
EP2644185A1 (en) | Thick cleaning composition | |
TWI488646B (en) | Emulsifying Cosmetics | |
BR112012027530B1 (en) | fabric softener composition, its use and its preparation processes, and aqueous rinse cycle fabric softener | |
JP2013147455A (en) | Gel-like detergent | |
CN101827578B (en) | Inverted vesicles | |
JP5700051B2 (en) | N-acyl basic amino acid dispersion | |
EA025647B1 (en) | Stable liquid cleansing compositions comprising critical window of hydrogenated triglyceride oils | |
JP2020094035A (en) | Solid hairdressing composition | |
TWI515013B (en) | Skin detergent composition | |
JP5623723B2 (en) | Skin cleanser | |
EP1411892B1 (en) | Aqueous narceous concentrate compositions comprising ethoxylated glycerides | |
JP6453665B2 (en) | Cleaning composition | |
WO2010090354A1 (en) | Thickener for the production of solid detergents | |
JP6378763B2 (en) | Effervescent personal care composition comprising a continuous oil phase | |
TW201437362A (en) | Viscous detergent composition | |
TW201309332A (en) | Method for producing a vesicle cpmposition | |
JP5691292B2 (en) | Skin cleanser composition | |
JP2008179543A (en) | Skin cleanser composition | |
JP7459418B2 (en) | Toner | |
JP2019001847A (en) | Detergent composition | |
JP2008013504A (en) | Oily cosmetic | |
JP2010043231A (en) | Gelling agent and gel composition | |
JP2023062607A (en) | Skin cleansing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |